Ronald E Myers1, Randa Sifri2, Constantine Daskalakis2, Melissa DiCarlo2, Praveen Ramakrishnan Geethakumari2, James Cocroft2, Christopher Minnick2, Nancy Brisbon2, Sally W Vernon2. 1. : Division of Population Science, Medical Oncology (REM, MD, JC), Department of Family and Community Medicine (RS, NB), and Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics (CD), Thomas Jefferson University, Philadelphia, PA; Department of Internal Medicine, Albert Einstein Healthcare Network (PRG); Cancer Center, Albert Einstein Healthcare Network, Philadelphia, PA (CM); Division of Health Promotion and Behavioral Sciences, Center for Health Promotion and Prevention Research, University of Texas School of Public Health, Houston, TX (SWV). ronald.myers@jefferson.edu. 2. : Division of Population Science, Medical Oncology (REM, MD, JC), Department of Family and Community Medicine (RS, NB), and Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics (CD), Thomas Jefferson University, Philadelphia, PA; Department of Internal Medicine, Albert Einstein Healthcare Network (PRG); Cancer Center, Albert Einstein Healthcare Network, Philadelphia, PA (CM); Division of Health Promotion and Behavioral Sciences, Center for Health Promotion and Prevention Research, University of Texas School of Public Health, Houston, TX (SWV).
Abstract
BACKGROUND: The study aimed to determine the effect of preference-based tailored navigation on colorectal cancer (CRC) screening adherence and related outcomes among African Americans (AAs). METHODS: We conducted a randomized controlled trial that included 764 AA patients who were age 50 to 75 years, were eligible for CRC screening, and had received care through primary care practices in Philadelphia. Consented patients completed a baseline telephone survey and were randomized to either a Standard Intervention (SI) group (n = 380) or a Tailored Navigation Intervention (TNI) group (n = 384). The SI group received a mailed stool blood test kit plus colonoscopy instructions, and a reminder. The TNI group received tailored navigation (a mailed stool blood test kit or colonoscopy instructions based on preference, plus telephone navigation) and a reminder. A six-month survey and a 12-month medical records review were completed to assess screening adherence, change in overall screening preference, and perceptions about screening. Multivariable analyses were performed to assess intervention impact on outcomes. RESULTS: At six months, adherence in the TNI group was statistically significantly higher than in the SI group (OR = 2.1, 95% CI = 1.5 to 2.9). Positive change in overall screening preference was also statistically significantly greater in the TNI group compared with the SI group (OR = 1.5, 95% CI = 1.0 to 2.3). There were no statistically significant differences in perceptions about screening between the study groups. CONCLUSIONS: Tailored navigation in primary care is a promising approach for increasing CRC screening among AAs. Research is needed to determine how to maximize intervention effects and to test intervention impact on race-related disparities in mortality and survival.
RCT Entities:
BACKGROUND: The study aimed to determine the effect of preference-based tailored navigation on colorectal cancer (CRC) screening adherence and related outcomes among African Americans (AAs). METHODS: We conducted a randomized controlled trial that included 764 AA patients who were age 50 to 75 years, were eligible for CRC screening, and had received care through primary care practices in Philadelphia. Consented patients completed a baseline telephone survey and were randomized to either a Standard Intervention (SI) group (n = 380) or a Tailored Navigation Intervention (TNI) group (n = 384). The SI group received a mailed stool blood test kit plus colonoscopy instructions, and a reminder. The TNI group received tailored navigation (a mailed stool blood test kit or colonoscopy instructions based on preference, plus telephone navigation) and a reminder. A six-month survey and a 12-month medical records review were completed to assess screening adherence, change in overall screening preference, and perceptions about screening. Multivariable analyses were performed to assess intervention impact on outcomes. RESULTS: At six months, adherence in the TNI group was statistically significantly higher than in the SI group (OR = 2.1, 95% CI = 1.5 to 2.9). Positive change in overall screening preference was also statistically significantly greater in the TNI group compared with the SI group (OR = 1.5, 95% CI = 1.0 to 2.3). There were no statistically significant differences in perceptions about screening between the study groups. CONCLUSIONS: Tailored navigation in primary care is a promising approach for increasing CRC screening among AAs. Research is needed to determine how to maximize intervention effects and to test intervention impact on race-related disparities in mortality and survival.
Authors: Resa M Jones; Steven H Woolf; Tina D Cunningham; Robert E Johnson; Alex H Krist; Stephen F Rothemich; Sally W Vernon Journal: Am J Prev Med Date: 2010-03-28 Impact factor: 5.043
Authors: John M Inadomi; Sandeep Vijan; Nancy K Janz; Angela Fagerlin; Jennifer P Thomas; Yunghui V Lin; Roxana Muñoz; Chim Lau; Ma Somsouk; Najwa El-Nachef; Rodney A Hayward Journal: Arch Intern Med Date: 2012-04-09
Authors: Ronald E Myers; Randa Sifri; Terry Hyslop; Michael Rosenthal; Sally W Vernon; James Cocroft; Thomas Wolf; Jocelyn Andrel; Richard Wender Journal: Cancer Date: 2007-11-01 Impact factor: 6.860
Authors: Sanja Percac-Lima; Richard W Grant; Alexander R Green; Jeffrey M Ashburner; Gloria Gamba; Sarah Oo; James M Richter; Steven J Atlas Journal: J Gen Intern Med Date: 2009-02 Impact factor: 5.128
Authors: Ronald E Myers; Terry Hyslop; Randa Sifri; Heather Bittner-Fagan; Nora C Katurakes; James Cocroft; Melissa Dicarlo; Thomas Wolf Journal: Med Care Date: 2008-09 Impact factor: 2.983
Authors: Gilda G Medina; Amy McQueen; Anthony J Greisinger; L Kay Bartholomew; Sally W Vernon Journal: Gastroenterol Res Pract Date: 2012-01-04 Impact factor: 2.260
Authors: Karen E Lasser; Jennifer Murillo; Elizabeth Medlin; Sandra Lisboa; Lisa Valley-Shah; Robert H Fletcher; Karen M Emmons; John Z Ayanian Journal: BMC Fam Pract Date: 2009-05-29 Impact factor: 2.497
Authors: Chuck Chan; Aristeo Lopez; Garland Castaneda; Taft Bhuket; Benny Liu; Stephen Yee; David Irwin; Robert J Wong Journal: J Community Health Date: 2017-08
Authors: Ronald E Myers; Karen Ruth; Sharon L Manne; James Cocroft; Randa Sifri; Barry Ziring; Desiree Burgh; Eric Ross; David S Weinberg Journal: J Behav Med Date: 2015-03-18
Authors: Charles E Basch; Patricia Zybert; Randi L Wolf; Corey H Basch; Ralph Ullman; Celia Shmukler; Fionnuala King; Alfred I Neugut; Steven Shea Journal: J Community Health Date: 2015-10
Authors: Folasade P May; Beth A Glenn; Catherine M Crespi; Ninez Ponce; Brennan M R Spiegel; Roshan Bastani Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-12-29 Impact factor: 4.254